Last reviewed · How we verify
NCT05504811
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
NA trial testing FitMi AD in Cognitive Dysfunction in 31 participants. Completed in 12 March 2025.
12 March 2025
Quick facts
| Lead sponsor | Flint Rehabilitation Devices, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 31 |
| Start date | 8 September 2023 |
| Primary completion | 12 March 2025 |
| Estimated completion | 12 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- FitMi AD
- Conventional exercise program
Conditions studied
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
- Dementia, Mild — all drugs for Dementia, Mild →
Sponsor
Flint Rehabilitation Devices, LLC — full company profile →
Who can join
50 and older, any sex, with Cognitive Dysfunction or Dementia, Mild. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05504811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Dysfunction
Currently open trials in the same condition.
- NCT07526740 — Brain Stimulation and Cognitive Training for MCI · NA · recruiting
- NCT07517237 — taVNS + CCT for Neurocognitive Rehab · NA · recruiting
- NCT07171450 — Cognitive Remediation · NA · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
Other Flint Rehabilitation Devices, LLC trials
Trials by the same sponsor.
- NCT06752707 — MiGo Tracker Remote Monitoring of Home Exercise After Stroke · NA · recruiting
- NCT03935425 — FitMi Plus Home Therapy for Stroke Patients · NA · completed
- NCT04471935 — Speech Hero Home Therapy for Aphasia · NA · completed
- NCT05655377 — FitMi PD Home Therapy for Parkinson's Disease · NA · completed
- NCT03503617 — RehabTouch Home Therapy for Stroke Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05504811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Flint Rehabilitation Devices, LLC
- Last refreshed: 24 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05504811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing